BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25060778)

  • 1. Low treatment rates in patients meeting guideline criteria in diverse practice settings.
    Kim LH; Nguyen VG; Trinh HN; Li J; Zhang JQ; Nguyen MH
    Dig Dis Sci; 2014 Sep; 59(9):2091-9. PubMed ID: 25060778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis B treatment eligibility and actual treatment rates in patients in community gastroenterology and primary care settings.
    Nguyen VG; Wan K; Trinh HN; Li J; Zhang JQ; Nguyen MH
    J Clin Gastroenterol; 2015 Feb; 49(2):145-9. PubMed ID: 25014233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undertreatment of Asian chronic hepatitis B patients on the basis of standard guidelines: a community-based study.
    Zhang S; Ristau JT; Trinh HN; Garcia RT; Nguyen HA; Nguyen MH
    Dig Dis Sci; 2012 May; 57(5):1373-83. PubMed ID: 22466077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and management of patients with chronic hepatitis B in an integrated care setting.
    Sarkar M; Shvachko VA; Ready JB; Pauly MP; Terrault NA; Peters MG; Manos MM
    Dig Dis Sci; 2014 Sep; 59(9):2100-8. PubMed ID: 24728968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
    Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
    Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor adherence to AASLD guidelines for chronic hepatitis B Management and treatment in a large academic medical center.
    Wu Y; Johnson KB; Roccaro G; Lopez J; Zheng H; Muiru A; Ufere N; Rajbhandari R; Kattan O; Chung RT
    Am J Gastroenterol; 2014 Jun; 109(6):867-75. PubMed ID: 24732869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Adherence to Guidelines for Treatment of Chronic Hepatitis B Virus Infection at Primary Care and Referral Practices.
    Nguyen VH; Le AK; Trinh HN; Chung M; Johnson T; Wong C; Wong C; Zhang J; Li J; Levitt BS; Nguyen HA; Nguyen KK; Henry L; Cheung R; Nguyen MH
    Clin Gastroenterol Hepatol; 2019 Apr; 17(5):957-967.e7. PubMed ID: 30326298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic hepatitis B management based on standard guidelines in community primary care and specialty clinics.
    Ku KC; Li J; Ha NB; Martin M; Nguyen VG; Nguyen MH
    Dig Dis Sci; 2013 Dec; 58(12):3626-33. PubMed ID: 24122622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment eligibility of patients with chronic hepatitis B initially ineligible for therapy.
    Nguyen NH; Nguyen V; Trinh HN; Lin B; Nguyen MH
    Clin Gastroenterol Hepatol; 2013 May; 11(5):565-71. PubMed ID: 23333662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to chronic hepatitis B treatment guideline recommendations for laboratory monitoring of patients who are not receiving antiviral treatment.
    Juday T; Tang H; Harris M; Powers AZ; Kim E; Hanna GJ
    J Gen Intern Med; 2011 Mar; 26(3):239-44. PubMed ID: 20978862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
    Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of advanced practice providers on characteristics and quality of care of patients with chronic hepatitis B.
    Kam LY; Huang DQ; Tobias AF; Poon K; Henry L; Kwo P; Cheung R; Nguyen MH
    Aliment Pharmacol Ther; 2022 Dec; 56(11-12):1591-1601. PubMed ID: 36266768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?
    Sung JJ; Amarapurkar D; Chan HL; Cheng J; Kao JH; Han KH; Piratvisuth T
    Antivir Ther; 2010; 15(4):607-16. PubMed ID: 20587854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Alanine Aminotransferase and Hepatitis B DNA Flares in Pregnant and Postpartum Women with Chronic Hepatitis B.
    Chang CY; Aziz N; Poongkunran M; Javaid A; Trinh HN; Lau D; Nguyen MH
    Am J Gastroenterol; 2016 Oct; 111(10):1410-1415. PubMed ID: 27456990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase and high levels of hepatitis B virus DNA.
    Chan HL; Chan CK; Hui AJ; Chan S; Poordad F; Chang TT; Mathurin P; Flaherty JF; Lin L; Corsa A; Gaggar A; Subramanian GM; McHutchison JG; Lau G; Lee S; Gane EJ
    Gastroenterology; 2014 May; 146(5):1240-8. PubMed ID: 24462735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B.
    Seo HY; Lee HA; Ko SY; Wang JH; Kim JH; Choe WH; Kwon SY
    Clin Mol Hepatol; 2017 Jun; 23(2):154-159. PubMed ID: 28479588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B surface antigen loss and sustained viral suppression in Asian chronic hepatitis B patients: A community-based real-world study.
    Wong RJ; Nguyen MT; Trinh HN; Chan C; Huynh A; Ly MT; Nguyen HA; Nguyen KK; Torres S; Yang J; Liu B; Garcia RT; Bhuket T; Baden R; Levitt B; da Silveira E; Gish RG
    J Viral Hepat; 2017 Dec; 24(12):1089-1097. PubMed ID: 28581644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic vaccination in chronic hepatitis B.
    Senturk H; Tabak F; Akdogan M; Erdem L; Mert A; Ozaras R; Sander E; Ozbay G; Badur S
    J Gastroenterol Hepatol; 2002 Jan; 17(1):72-6. PubMed ID: 11895556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase≤2 upper limit of normal.
    Gao S; Fan YC; Zhao J; Sun FK; Han J; Zhao ZH; Wang K
    Liver Int; 2014 Aug; 34(7):e229-37. PubMed ID: 24112455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halting the natural history of hepatitis B viral infection: a paradigm shift.
    Perrillo RP; Jacobson IM
    Semin Liver Dis; 2007 Aug; 27 Suppl 1():3-8. PubMed ID: 17701844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.